Skip to main content

Novel Apoptotic Regulators in Carcinogenesis

  • Book
  • © 2012

Overview

  • Description of a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment
  • 11 chapters written by established leaders in the world
  • Valuable tools for academics working in the field of cancer research and apoptosis as well as pharmaceutical and pharmacological industries

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (11 chapters)

Keywords

About this book

Our recent understanding of the cellular and molecular defects and the regulation of the apoptotic signalling pathways has resulted in rationally designed anticancer strategies and the development of novel agents that regulates apoptosis. A comprehensive review of all apoptotic-related anticancer therapies is not the purpose of this book. However, in the volume of this book with 11 chapters, we have described a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment. These novel agents either occur naturally or are chemically synthesized. While we are excited about the discovery and development of these novel apoptotic regulators as potential anticancer agents, a degree of caution should be always borne in mind when interpreting the success of preclinical pro-apoptotic candidates since potential problems inevitably lie ahead. These problems usually include target specificity, unanticipated toxicity, compound stability, formulation issues, pharmacokinetic and pharmacodynamic profiles. Nevertheless, we believe that this collection of 11 chapters by established leaders in the area of apoptosis will be of great interest to not only academics working in the field of cancer research and apoptosis but also pharmaceutical and pharmacological industries that . We are looking forward to the further development to push these potential agents toward clinical stage.

Reviews

From the reviews:

“This book is appropriate for scientific professionals in the field of basic cancer research, drug development, and cancer medicine, as well as professionals in the pharmaceutical and pharmacological industries. … This book provides well-summarized information on interesting anticancer agents which have been substantially studied recently on their ability to induce apoptosis in cancer cells. … The book is a good source of information for the scientific community and medicinal industries who are interested in development of anticancer drugs.” (Qi Chen, Doody’s Review Service, January, 2013)

Editors and Affiliations

  • , Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR

    George G. Chen, Paul B.S. Lai

Bibliographic Information

  • Book Title: Novel Apoptotic Regulators in Carcinogenesis

  • Editors: George G. Chen, Paul B.S. Lai

  • DOI: https://doi.org/10.1007/978-94-007-4917-7

  • Publisher: Springer Dordrecht

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer Science+Business Media Dordrecht 2012

  • Hardcover ISBN: 978-94-007-4916-0Published: 21 August 2012

  • Softcover ISBN: 978-94-007-9493-1Published: 21 September 2014

  • eBook ISBN: 978-94-007-4917-7Published: 28 August 2012

  • Edition Number: 1

  • Number of Pages: XII, 300

  • Topics: Biomedicine general, Medicine/Public Health, general, Entomology

Publish with us